The Wegovy pill is the first and only oral GLP-1 for weight loss in adults. The first and only oral GLP-1 for weight loss in adults is now available to consumers. Drugmaker Novo Nordisk announced ...

Imagine this scenario: You’ve been diligently working toward your weight management goals, and your healthcare team has prescribed Wegovy (semaglutide). You’re excited, you’ve done your research, and ...

It might be time to dust off that Costco card. The wholesale giant has partnered with Danish drugmaker Novo Nordisk to offer blockbuster weight-loss medications like Ozempic and Wegovy at deep ...

The weight-loss drug market just got more crowded — and a lot less painful. The FDA on Monday approved a daily pill version of Novo Nordisk’s Wegovy, making it the first oral GLP-1 obesity treatment ...

A pill version of the blockbuster weight-loss medication Wegovy is rolling out in the U.S., and people are already actively navigating prescriptions. Experts say that a pill version of the high-demand ...

Anything that helps Americans lose weight, reduces treatment barriers and makes care more affordable should be welcomed. But let's not fool ourselves.

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection. Patients with a prescription could obtain the starter 1.5 mg dose of the tablet ...

Some tout a daily semaglutide pill as a game-changer for weight-loss treatment. The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo ...

Zepbound (tirzepatide) and Wegovy (semaglutide) are FDA-approved injectable medications revolutionizing weight management. Both belong to the incretin mimetic drug class but differ in their mechanisms ...

There’s no question that medications like semaglutide (Wegovy) and tirzepatide (Zepbound) make headlines. They’re two of the handful of medications approved specifically for weight loss. While both ...

The Wegovy pill launched Monday, and the starting dose is now available at pharmacies around the country with higher doses arriving by the end of the week. The Food and Drug Administration approved ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. The launch this week of an oral pill version of Wegovy ...